Keystone Symposia – 2025 – Oral Presentation […]
Read More… from Genome Engineered Hematopoietic Transplants for the Treatment of AML
Publication Programs: Platform
Clinical Holds for Cell and Gene Therapy Trials: Risks, Impact, and Lessons Learned
Molecular Therapy: Methods & Clinical Development – Review […]
Read More… from Clinical Holds for Cell and Gene Therapy Trials: Risks, Impact, and Lessons Learned
Development of a Gene Edited Next-Generation Hematopoietic Cell Transplant to Enable Acute Myeloid Leukemia Treatment by Solving Off-Tumor Toxicity
Molecular Therapy: Methods & Clinical Development – Peer-Reviewed Manuscript […]
Gene Editing and Immunotherapeutic Targeting of ADGRE2/EMR2 to Enable Combinatorial Targeting in Acute Myeloid Leukemia (AML)
ASGCT – 2023 – Poster Presentation 618 […]
Translocation Detection and Quantification Workflow to Characterize CRISPR-Cas Multiplex Edited Hematopoietic Stem and Progenitor Cells (HSPCs)
Keystone Symposia – 2023 – Poster Presentation 3527 […]
Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers
Cell & Gene – White Paper […]
Read More… from Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers
A Machine Learning Approach Incorporating Germline Information Improves Genotyping of CRISPR-Cas9 Gene Editing Events at Single Cell Resolution
Rocky Conference – 2022 – Poster Presentation 71 […]
Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment
Functional Validation of Single Domain Antibody-Derived CD33 Specific CAR-T Cells for the Treatment of Acute Myeloid Leukemia
SITC – 2022 – Poster Presentation P334 […]